Medicus Pharma Ltd. (MDCXW) Accumulated Expenses (2023 - 2026)

Medicus Pharma (MDCXW) has 3 years of Accumulated Expenses data on file, last reported at $995290.0 in Q4 2025.

• Quarterly Accumulated Expenses rose 30.47% year-over-year to $995290.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $995290.0 (up 30.47% YoY) and the FY2025 annual result came in at $995290.0, up 30.47% from the prior year.
• Accumulated Expenses fell to $995290.0 in Q4 2025, from $1.6 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $1.8 million in Q2 2025 to a low of $404817.0 in Q4 2023.
• A 3-year average of $1.1 million and a median of $1.0 million in 2025 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2024 — Accumulated Expenses surged 88.44% — and 2025, when it soared 30.47%.
• Tracing MDCXW's Accumulated Expenses over 3 years: stood at $404817.0 in 2023, then jumped by 88.44% to $762835.0 in 2024, then soared by 30.47% to $995290.0 in 2025.
• The last three Accumulated Expenses figures came in at $995290.0 (Q4 2025), $1.6 million (Q3 2025), and $1.8 million (Q2 2025), per Business Quant data.